DCD and pancreatic adenocarcinoma: Five samples (45.5%) expressed DCD mRNA, three of which had CT values 25.5–30.5 defined as high levels of expression (Table 1): 2 metastatic pancreatic adenocarcinomas and one poorly differentiated cholangiocarcinoma.